Details for New Drug Application (NDA): 020400
✉ Email this page to a colleague
NDA 020400 describes AVITA, which is a drug marketed by Mylan Pharms Inc and Norvium Bioscience and is included in two NDAs. It is available from two suppliers. Additional details are available on the AVITA profile page.
The generic ingredient in AVITA is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
The generic ingredient in AVITA is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Summary for 020400
| Tradename: | AVITA |
| Applicant: | Norvium Bioscience |
| Ingredient: | tretinoin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020400
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL;TOPICAL | Strength | 0.025% | ||||
| Approval Date: | Jan 29, 1998 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
